United StatesSemaglutide Inj (2 mg x 10, NDC 84223-001-07; 2 mg x 5, NDC 84223-001-06) and Tirzepatide Inj (10 mg, NDC 84223-002-03; 15 mg x 4, NDC 84223-002-04) sterile multi-dose vials labeled Nomida from New Life Pharma LLC (Olathe/Northvale) — lots 241113 (exp 11/30/2026) and 250103 (exp 1/31/2027); lot 240903 (exp 9/30/2026); lot 240709 (exp 7/31/2026); quantities 820, 2, 23, and 45 vials — sold in OH are affected. They were recalled due to lack of assurance of sterility.
What's being recalled
Semaglutide Inj, 2mg x 10, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-07.
Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-06
Tirzepatide Inj, 10mg, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-03.
Tirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-04.
Recalling firm: New Life Pharma LLC, Northvale, NJ, United States.
How to identify it
Lot 241113, Exp Date 11/30/2026 & Lot 250103, Exp Date 1/31/2027 Lot 240903, exp 9/30/2026 Lot 240709, exp 7/31/2026
The hazard
Lack of Assurance of Sterility
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
OH
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)